• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NYR 1.03% 9.8¢

NYRADA INC.

Nyrada Inc is an Australia-based drug development company. The Company focuses on... Nyrada Inc is an Australia-based drug development company. The Company focuses on development of small molecule drugs pertaining to the underlying pathological processes involved in cardiovascular, neurodegenerative and chronic inflammatory diseases. Its drug development programs include a proprotein convertase subtilisin/kexin type nine (PCSK9) inhibitor for the treatment of high blood low-density lipoprotein (LDL)-cholesterol levels in patients poorly responsive to or unable to take statin drugs. It develops a neuroprotectant drug to reduce the impact of long-term disability in patients with ischaemic stroke and traumatic brain injury. The Company also develops a drug to treat pain associated with peripheral nerve damage and autoimmune diseases such as psoriasis.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
NYR 19/04/24 3 740
19/04/24 Last post  Roch2077 Comments Created with Sketch.  3  Views Created with Sketch.  740 
NYR 17/04/24 41 8.7K
17/04/24 Last post  Roch2077 Comments Created with Sketch.  41  Views Created with Sketch.  8.7K 
NYR 11/04/24 1 461
11/04/24 Last post  ASX News Comments Created with Sketch.  1  Views Created with Sketch.  461 
NYR
Charting
09/04/24 6 2.0K
09/04/24 Last post  Roch2077 Comments Created with Sketch.  6  Views Created with Sketch.  2.0K 
NYR
Nyrada Talks PreClinical Success with 180 Markets
2
08/04/24 91 37K
08/04/24 Last post  Fencepost Comments Created with Sketch.  91  Views Created with Sketch.  37K 
NYR 04/04/24 4 1.2K
04/04/24 Last post  Roch2077 Comments Created with Sketch.  4  Views Created with Sketch.  1.2K 
NYR 02/04/24 0 189
02/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  189 
NYR 29/03/24 2 1.1K
29/03/24 Last post  Roch2077 Comments Created with Sketch.  2  Views Created with Sketch.  1.1K 

See All Discussions arrow Created with Sketch.

Timeline

Investor Presentation - April 2024
18 Apr 08:26
 
3QFY2024 Results and Investor Conference Call
11 Apr 11:53
 
Quarterly Activities Report and Appendix 4C
10 Apr 09:42
 
2024 EGM Letter to Shareholders and Proxy
02 Apr 08:26
 
2024 EGM Notice of Meeting and Proxy
02 Apr 08:26
 
Nyrada Commences Key Brain Injury Program Preclinical Study
28 Mar 09:14
 
View More arrow Created with Sketch.
(20min delay)
Last
9.8¢
Change
0.001(1.03%)
Mkt cap ! $17.58M
Open High Low Value Volume
9.9¢ 10.0¢ 9.8¢ $29.56K 298.3K

Buyers (Bids)

No. Vol. Price($)
1 9382 9.8¢
 

Sellers (Offers)

Price($) Vol. No.
10.0¢ 48000 2
View Market Depth
Last trade - 16.10pm 19/04/2024 (20 minute delay) ?
Last
10.0¢
  Change
0.001 ( 0.60 %)
Open High Low Volume
9.8¢ 10.0¢ 9.8¢ 137767
Last updated 15.43pm 19/04/2024 ?
NYR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.